4-methyl-N-(3-(trifluoromethyl)phenyl)benzenesulfonamide

ID: ALA1170012

Cas Number: 1584-58-3

PubChem CID: 837245

Max Phase: Preclinical

Molecular Formula: C14H12F3NO2S

Molecular Weight: 315.32

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1

Standard InChI:  InChI=1S/C14H12F3NO2S/c1-10-5-7-13(8-6-10)21(19,20)18-12-4-2-3-11(9-12)14(15,16)17/h2-9,18H,1H3

Standard InChI Key:  LAQWXSZWFLYJOE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  0  0  0  0  0  0999 V2000
   -2.7976    1.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7988    0.2575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0838   -0.1556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3670    0.2580    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3715    1.0914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0855    1.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6568    1.5040    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0578    1.0914    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    0.4704    1.8061    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3548    0.3767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7725    0.6788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7700   -0.1435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4827   -0.5527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1945   -0.1398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1897    0.6851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4779    1.0905    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0838   -0.9809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9093   -0.9809    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2588   -0.9809    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0838   -1.8061    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    2.9093   -0.5525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  8 11  1  0
  5  6  2  0
 11 12  2  0
  6  1  1  0
 12 13  1  0
  1  2  2  0
 13 14  2  0
  5  7  1  0
 14 15  1  0
  3  4  2  0
 15 16  2  0
 16 11  1  0
  7  8  1  0
  3 17  1  0
 17 18  1  0
  8  9  2  0
 17 19  1  0
  4  5  1  0
 17 20  1  0
  8 10  2  0
 14 21  1  0
M  END

Associated Targets(Human)

CCNH Tbio Cyclin-dependent kinase 7/ cyclin H (714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCND1 Tchem CDK6/cyclin D1 (322 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK1 Tchem Cyclin-dependent kinase 1/cyclin B1 (1887 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK2 Tchem Cyclin-dependent kinase 2/cyclin A (2220 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LoVo (4724 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR4 Tchem G-protein coupled receptor 120 (2999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FFAR1 Tchem Free fatty acid receptor 1 (4763 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pfmrk Protein kinase Pfmrk (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 315.32Molecular Weight (Monoisotopic): 315.0541AlogP: 3.81#Rotatable Bonds: 3
Polar Surface Area: 46.17Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.94CX Basic pKa: CX LogP: 3.85CX LogD: 3.76
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.94Np Likeness Score: -1.95

References

1. Caridha D, Kathcart AK, Jirage D, Waters NC..  (2010)  Activity of substituted thiophene sulfonamides against malarial and mammalian cyclin dependent protein kinases.,  20  (13): [PMID:20627564] [10.1016/j.bmcl.2010.05.039]
2. Xu F,Zhao Y,Zhou H,Li C,Zhang X,Hou T,Qu L,Wei L,Wang J,Liu Y,Liang X.  (2020)  Synthesis and evaluation of 3-(4-(phenoxymethyl)phenyl)propanoic acid and N-phenylbenzenesulfonamide derivatives as FFA4 agonists.,  30  (24): [PMID:33127539] [10.1016/j.bmcl.2020.127650]

Source